IP Library Granted Patent US 11,278,477
Granted Patent B2
US 11,278,477 · App. 16/414,847 · Granted Mar 22, 2022

Dentifrice composition comprising zinc oxide and zinc citrate

Inventors: Michael Prencipe (West Windsor, NJ); Yun Xu (Langhorne, PA); Xiao Yi Huang (Guangzhou, CN); Steven Fisher (Middlesex, NJ); Betty Won (Princeton Junction, NJ); Lyndsay Schaeffer-Korbylo (Flemington, NJ)
Assignee: Colgate-Palmolive Company
A61K8/27A61Q11/00A61K2800/5922
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,278,477
App. No.
16/414,847
Granted
Mar 22, 2022
Kind
B2
Abstract

Described herein are oral care compositions comprising a combination of zinc oxide and zinc citrate, and methods of preparing and using the same.

Claims (13)

1. An oral care composition having synergistic zinc antibacterial effects comprising zinc oxide and zinc citrate

wherein the weight ratio of zinc oxide: zinc citrate is 2:1, and wherein the amount of zinc oxide is 0.5 to 1.5% and the amount of zinc citrate is 0.25 to 0.75%, by weight of composition;

wherein the composition comprises sodium fluoride;

wherein the composition exhibits antibacterial effects measured as reduction in colony forming units after the composition is applied to incubated hydroxyapatite disks, which are incubated for 8 days, collected aseptically, and transferred to a half-strength, pre-reduced, thioglycollate medium; and

wherein the composition further comprises sodium lauryl sulfate.

2. The composition of claim 1 , wherein the amount of zinc oxide is 1% and the amount of zinc citrate is 0.5%.

3. The composition of claim 1 , further comprising an orally acceptable carrier.

4. The composition of claim 1 in the form of a dentifrice.

5. The composition of claim 1 in the form of a toothpaste or tooth gel.

6. The composition of claim 1 , wherein the composition comprises greater than 15%, by weight, free water.

7. A method of treating or preventing a disease or condition of the oral cavity comprising contacting an oral cavity surface of a patient in need thereof with the composition of claim 1 .

8. The method of claim 7 , wherein the disease or condition of the oral cavity is halitosis.

9. A method of reducing or inhibiting biofilm formation in an oral cavity comprising applying a composition according to claim 1 .

Priority Claims (1)
CN 201310701692.8 · Dec 19, 2013 · national
Continuity (2)
Continuation 15106280
Related Publication 20190269586A1 · Sep 5, 2019
Cited By (1)
US 12,622,865